The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. John Smyth

Prof. John Smyth is Chairperson of CDDF Board of Directors (2019 – November 2022)

John Smyth is Emeritus Professor of Medical Oncology in the University of Edinburgh, where his major research interest has been the development and evaluation of new anti-cancer drugs.

He has published over 350 papers and is past Editor-in-Chief of the European Journal of Cancer.

He served for several years on the UK Committee on Safety of Medicines and has served on the Scientific Advisory Group for Oncology to the EMEA.

He is a fellow of the Royal College of Physicians of Edinburgh and London, and fellow of the Royal Society of Edinburgh.

He is a past-president of the European Society of Medical Oncology and was from 2005 – 2007 President of the Federation of European Cancer Societies.

View current disclosure here

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70